Early lung cancer diagnosis & treatment with AI
Early lung cancer diagnosis & treatment with AI
Optellum was founded so that every lung cancer patient is diagnosed & treated at the earliest stage, and cured
Optellum’s initial product is the first Decision Support software for personalized early diagnosis & treatment of lung cancer, which enables every clinician, in every hospital, to manage their patients in the optimal way. It is based on Machine Learning technologies applied to the world’s largest clinical dataset.
We are a team of medical device, machine learning, and clinical experts who met at Oxford’s renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO.Learn more at optellum.com.
Optellum’s initial product is the first Decision Support software for personalized early diagnosis & treatment of lung cancer, which enables every clinician, in every hospital, to manage their patients in the optimal way. It is based on Machine Learning technologies applied to the world’s largest clinical dataset.
We are a team of medical device, machine learning, and clinical experts who met at Oxford’s renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO.Learn more at optellum.com.
Founders
View all team members
Founder & VP R&D @Optellum. Visiting Scientist @University of Oxford. Previously Director Clinical Applications Research @Siemens. PhD @INRIA
Founded Oxford Robotics Research Group; Serial Entrepreneur: Guidance Ltd., Mirada Solutions, Mirada Medical, Volpara, Perspectum Diagnostics, ScreenPoint
Founder & CEO @Optellum. Previously Product Lead at Hocoma AG. PhD @University of Oxford @University of Cambridge. Passion for @Mountaineering
